Upcoming ePRO Webinars
- Thursday, February 23, 2012 11:00 a.m. EST (1 hour)
Back to Basics: ePRO Basics & Fundamentals
Speaker:
Jane Carter, Program Manager, CRF Health
- Thursday, March 1, 2012 1:00 p.m. EST (1 hour)
Co-Presenting with PRA
The Biotech Essential Guide to ePRO: Benefits of Partnership Between CROs and ePRO Providers
Speakers:
Chris Clancy, Director of Business Development, CRF Health
Christine Kanalis, Manager, Clinical Data Management, PRA
Previously Recorded ePRO Webinars
- Session 1: January: ePRO Deployment Basics
- Session 2: February: Integration of ePRO with Medication Management Using
a Barcode Scanner
- Session 3: March: Reminders - Alerts & Other Mechanisms to
Promote Maximum Patient Compliance
- Session 4: April: Deployment to India / Japan and Other Challenging Places
- Session 5: May: Instrument Validation, Psychometric Testing Including a Discussion of FDA Guidance and ISPOR
-
Session 6: June: ePRO Discrepancy Management - How to Efficiently Clean ePRO Data and Resolve Discrepancies
- Session 7: July: Tips for Successful Translation & Localization of ePRO Applications for Global Studies
- Session 8: August: The Importance of Web-Based, Real-Time Reports for Global ePRO Projects
- Session 9: September: The Advantages of ePRO For Pain Studies
- Session 10: October: Helpdesk Support for Sites, Subjects, and Sponsor Teams for Global ePRO Deployment
- Session 11: November: Making the Transition from Paper to ePRO: An Industry Perspective
- Europe Session 1: The Value Proposition of ePRO Compared to Paper PRO
- Session 12: December: ePRO Benefits and Burdens from the Site Perspective
- Session 13: January 2010: Industry Perspectives on the Final PRO Guidance Document Focusing on ePRO: Are there any eCONS?
- Session 14: February: The Value Proposition of ePRO Compared to Paper PRO
- Session 15: March: A Better View: Integrating ePRO and EDC for More Comprehensive Patient Data
- Session 16: April: FDA PRO Guidance Compliance: Practical PRO/ePRO Instrument Equivalence Tips
- Session 17: May: ePRO Devices - Practical and Regulatory Considerations
- Session 18: June: Back to Basics: ePRO Basics & Fundamentals
- Session 19: July: ePRO Design and Implementation: What to Expect During the Design of an ePRO Solution for Your Project
- Session 20: August: How to Maximize Patient Comliance Using ePRO
- Session 21: September: Using Real-Time Reports in ePRO Studies to Better Manage Your Sites & Patients
- Session 22: October: Deploying ePRO in Challenging Geographic Locations, Languages, and Cultures
- Session 23: November: Back to Basics: ePRO Basics & Fundamentals
- Session 24: December: Which ePRO Solution is Right for Your Study? Bringing Clarity to ePRO Choices
Part 1: Home Based & Site Based ePRO Solutions are Examined
- Session 25: January 2011: Which ePRO Solution is Right for Your Study? Bringing Clarity to ePRO Choices
Part 2: ePRO Via SMS, Web, or Phone
- Session 27: February 2011: Generating the Evidence Required for Content Validity
- Session 28: March 2011: CRO ePRO Delivery: Best Practices, Part I
- Session 29: April 2011: CRO ePRO Delivery: Best Practices, Part II
- Session 30: May 2011: The Patient Perspective: Feedback/Opinions on Various ePRO Modalities
- Session 31: June 2011: Considerations for the Use of eDiaries in Parkinson's Disease Clinical Trials
- Session 32: July 2011: How to Realize Time and Cost Savings By Standardizing ePRO Deployment
- Session 33: August 2011: Compliance in Challenging Patient Populations and the Role of the Caregiver
- Session 34: September 2011: Multiple Sclerosis Clinical Trials - ePRO and eClinRO Best Practices
- Session 35 (EU): September 2011: Efficient Integration of ePRO and Other eClinical Systems for the Benefit of Clinical Studies
- Session 36: October 2011: Efficient Integration of ePRO and Other eClinical Systems for the Benefit of Clinical Studies
- Session 37: November 2011: Detecting Pro-Cognitive Effects in Clinical Drug Trials: Case Studies from Alzheimer’s Disease
- Session 38: December 2011: The Benefits of Web-Based ePRO for Phase IV Clinical Studies
- Session 39: January 2012: Clinical Outcome Assessments: Considerations in Migration & Validation
|